News

Filter

Current filters:

Licensing

51 to 60 of 1777 results

AC Immune out-licenses anti-Tau vaccine to Janssen in up to $509 million deal

12-01-2015

Switzerland’s biopharma company AC Immune has entered into a worldwide exclusive license agreement…

AC ImmuneBiotechnologyGlobalJanssen Research & DevelopmentJohnson & JohnsonLicensingNeurological

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

12-01-2015

Swiss drugmaker Mundipharma Laboratories and its independent associated company, Purdue Pharmaceuticals,…

E-52862E-58425Esteve GroupLicensingMundipharmaNeurologicalPharmaceuticalPurdue PharmaResearch

Egalet buys in two innovative approved pain products, Oxaydo and Sprix

09-01-2015

US biotech firm Egalet Corp has in-licensing two innovative approved pain products transforming Egalet…

Acura PharmaceuticalsBiotechnologyDaiichi SankyoEgalet CorpGlobalLicensingLuitpold PharmaNeurologicalOxaydoSPRIX

SinSa Labs signs license agreement for technology platform leading to new antibiotics

SinSa Labs signs license agreement for technology platform leading to new antibiotics

09-01-2015

Singapore-based SinSa Labs has signed a license agreement with Singapore Health Services and technology…

Antibiotics and Infectious diseasesDorzidinLicensingPharmaceuticalResearchSingaporeSinSa Labs

Biotech industry shatters key fundraising records in 2014

08-01-2015

The biotech industry shattered records for venture investment, IPOs (initial public offerings) and M&A…

BiotechnologyFinancialGlobalLicensing

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

08-01-2015

Shares of Japanese mid-size drugmaker Kyowa Hakko Kirin rose 3.55% to 1,138 yen by afternoon trading…

Asia-PacificentinostatJapanKyowa Hakko KirinLicensingOncologyPharmaceuticalSyndax Pharmaceuticals

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

08-01-2015

Swiss oncology specialist Helsinn and Danish anemia drugmaker Pharmacosmos have entered into an agreement…

HelsinnHematologyLicensingMarkets & MarketingMonoferPharmaceuticalPharmacosmos

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

08-01-2015

Swiss drug major Novartis has signed collaboration and licensing agreements with Intellia Therapeutics…

GeneticsLicensingNovartisPharmaceuticalSwitzerland

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

51 to 60 of 1777 results

COMPANY SPOTLIGHT

Menarini

Back to top